Newsroom - Page 11

Groups say the approach of the Republicans' plan moves away from prevention, which had been a chief aim of the Affordable Care Act. A large cut to the CDC would leave the future of the Diabetes Prevention Program unclear.
Researchers from the Mayo Clinic and Arizona State University’s Biodesign Institute have collaborated to identify biological markers in the blood of patients with Crohn’s disease, spurring optimism that a simple blood test could be developed to accurately diagnose the disease.
New research published in Nature Medicine has identified a broader population of individuals with breast cancer who can have therapeutic sensitivity to PARP inhibitors.
Verma is best-known as the designer of Indiana's Medicaid expansion program, which features a lockout provision for those who fail to pay premiums.
The FDA has approved Novartis’ ribociclib (Kisqali) for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.
Up to 24 million people would lose health coverage under the American Health Care Act, the Republican plan to replace the Affordable Care Act (ACA), according to a report released today by the Congressional Budget Office (CBO). That would include up to 14 million in the first year alone, or two-thirds of the 21 million who have gained coverage under the ACA.
The technology outlined in the study not only offers superior glucose control, but it also is being developed in forms that its creators say will be functional and discreet.
Compendia
Clinical Pathways Compendium
COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
$AD300x250BB$